Sirdalud

Medicinal product

(Invented) name

Sirdalud

Active substance (s)

Tizanidinas

Strength

4 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M03BX02, Tizanidine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-03-14

Date of renewal

Documents

2424_Sirdalud_4mg_tab_N100_PZ.docx

2423_2424_Sirdalud_2mg_4mg_tab_N100_PIL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Tizanidinas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116973	103076	1103076	lizdinė plokštelė	N100		Receptinis	LT/L/25/2424/001	Netiekiama	-	2025-06-24	No	-	-	Download

Stadijos

Data	Stadija
2025-03-14	Registruotas